National Philanthropic Trust’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$846K Buy
17,646
+265
+2% +$11.4K 0.01% 247
2026
Q1
$639K Buy
17,381
+12,500
+256% +$592K 0.01% 250
2025
Q4
$248K Buy
+4,881
New +$250K ﹤0.01% 346
2024
Q2
Sell
-1,590
Closed -$204K 270
2024
Q1
$204K Sell
1,590
-1,674
-51% -$199K ﹤0.01% 251
2023
Q4
$338K Buy
+3,264
New +$323K 0.01% 235

Other funds holding NVO

National Philanthropic Trust's NVO Position: Q2 2026 in Review

National Philanthropic Trust increased its Novo Nordisk (NVO) stake by 1.5% in Q2 2026, buying an estimated $11.4K and bringing the position to 17,646 shares worth $846K. The position accounts for 0.01% of the portfolio, ranked #247.

National Philanthropic Trust first reported a position in NVO in Q4 2023 and has held it in 5 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • National Philanthropic Trust held 17,646 shares of Novo Nordisk worth $846K as of Q2 2026.
  • National Philanthropic Trust bought 265 Novo Nordisk shares in Q2 2026, an estimated $11.4K.
  • Novo Nordisk made up 0.01% of National Philanthropic Trust's portfolio in Q2 2026, its #247 holding.
  • National Philanthropic Trust first reported a position in Novo Nordisk in Q4 2023 and has held it in 5 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on National Philanthropic Trust's 13F filing for Q2 2026, filed 14 Aug 2026.